We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+7.51%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$25.3B
AUM Growth
+$5.49B
Cap. Flow
+$2.44B
Cap. Flow %
9.65%
Top 10 Hldgs %
19.18%
Holding
3,786
New
851
Increased
1,117
Reduced
1,039
Closed
652

Top Sells

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$142M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$94.7M
3
WDAY icon
Workday
WDAY
+$80M
4
SHW icon
Sherwin-Williams
SHW
+$72.3M
5
MMM icon
3M
MMM
+$60.4M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 10.27%
2 Technology 10.11%
3 Healthcare 6.67%
4 Financials 6.57%
5 Industrials 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PUMP icon
2926
ProPetro Holding
PUMP
$1.45B
$125K ﹤0.01%
12,006
-145,450
-92% -$1.53M
BLNK icon
2927
Blink Charging
BLNK
$75.2M
$124K ﹤0.01%
11,276
-26,422
-70% -$360K
SHC icon
2928
Sotera Health
SHC
$4.95B
$124K ﹤0.01%
14,837
-211,859
-93% -$1.58M
RLX icon
2929
RLX Technology
RLX
$2.48B
$123K ﹤0.01%
53,603
+11,013
+26% +$19.5K
BCAB icon
2930
BioAtla
BCAB
$5.59M
$123K ﹤0.01%
+299
New +$124K
RLMD icon
2931
Relmada Therapeutics
RLMD
$544M
$123K ﹤0.01%
+35,281
New +$310K
TNYA icon
2932
Tenaya Therapeutics
TNYA
$168M
$123K ﹤0.01%
+61,167
New +$149K
EBS icon
2933
Emergent Biosolutions
EBS
$375M
$123K ﹤0.01%
10,409
-3,771
-27% -$58.4K
NVTS icon
2934
Navitas Semiconductor
NVTS
$2.66B
$123K ﹤0.01%
34,974
+15,614
+81% +$66.9K
DSEY
2935
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
$122K ﹤0.01%
+28,741
New +$141K
IPSC icon
2936
Century Therapeutics
IPSC
$381M
$122K ﹤0.01%
+23,866
New +$225K
AOMR
2937
Angel Oak Mortgage REIT
AOMR
$219M
$122K ﹤0.01%
+25,855
New +$214K
LUMN icon
2938
CALL
Lumen
LUMN
$6.53B
$121K ﹤0.01%
23,200
-10,200
-31% -$62.7K
CRON
2939
Cronos Group
CRON
$1.05B
$119K ﹤0.01%
46,994
+23,494
+100% +$68.9K
EGIO
2940
DELISTED
Edgio, Inc. Common Stock
EGIO
$119K ﹤0.01%
2,622
-1,871
-42% -$144K
TTI icon
2941
TETRA Technologies
TTI
$1.23B
$118K ﹤0.01%
34,244
+18,515
+118% +$72K
ADAM
2942
Adamas Trust
ADAM
$777M
$117K ﹤0.01%
+11,448
New +$122K
VERI icon
2943
Veritone
VERI
$96.7M
$116K ﹤0.01%
+21,963
New +$141K
LFCR icon
2944
Lifecore Biomedical
LFCR
$162M
$115K ﹤0.01%
+17,789
New +$147K
OABI icon
2945
OmniAb
OABI
$294M
$115K ﹤0.01%
+32,000
New +$168K
DFH icon
2946
Dream Finders Homes
DFH
$1.46B
$115K ﹤0.01%
+13,286
New +$133K
SABR icon
2947
Sabre
SABR
$656M
$115K ﹤0.01%
18,533
-261,657
-93% -$1.46M
ADMA icon
2948
ADMA Biologics
ADMA
$1.92B
$114K ﹤0.01%
+29,334
New +$90.5K
IMMR icon
2949
Immersion
IMMR
$216M
$113K ﹤0.01%
+16,097
New +$104K
GNE icon
2950
Genie Energy
GNE
$378M
$113K ﹤0.01%
+10,937
New +$106K

Similar funds

Squarepoint's Q4 2022 Portfolio in Review

As of Q4 2022, Squarepoint held 3,786 positions worth $25.3B, up 28% from $19.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Squarepoint deployed $2.44B of net new capital in Q4 2022, opening 851 new positions and adding to 1,117 existing holdings. Its largest new stake was Walmart Inc: 3,657,033 shares worth $173M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 10% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Comcast, an estimated $142M trimmed.

  • Squarepoint's largest Q4 2022 buy was Walmart Inc: 3,657,033 shares worth $173M.
  • Squarepoint added most to Apple in Q4 2022, an estimated $252M increase.
  • Squarepoint's biggest Q4 2022 reduction was Comcast, cutting an estimated $142M.
  • Squarepoint fully exited iShares Russell 2000 ETF in Q4 2022, selling an estimated $59.4M.
  • Squarepoint's ten largest holdings make up 19% of its $25.3B portfolio in Q4 2022.
  • Squarepoint opened 851 new positions and closed 652 in Q4 2022.
  • Squarepoint's portfolio value rose 28% quarter-over-quarter to $25.3B.

Based on Squarepoint's 13F filing for Q4 2022, filed 14 Feb 2023.